We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
151
Verition Fund Management
Connecticut
– -$4.01M -12,665 Closed
GI
152
GAMCO Investors
Connecticut
– -$3.97M -12,540 Closed
PCM
153
Patient Capital Management
Maryland
– -$3.68M -11,631 Closed
Marshall Wace
154
Marshall Wace
United Kingdom
– -$3.6M -11,359 Closed
CAC
155
Cowen and Company
New York
– -$3.48M -10,999 Closed
Nomura Asset Management
156
Nomura Asset Management
Japan
– -$3.44M -10,883 Closed
First Trust Advisors
157
First Trust Advisors
Illinois
– -$3.17M -10,020 Closed
ACM
158
ADAR1 Capital Management
Texas
– -$3.17M -10,000 Closed
TCM
159
Tang Capital Management
California
– -$3.17M -10,000 Closed
NIP
160
Nicholas Investment Partners
California
– -$3.05M -9,644 Closed
ASRS
161
Arizona State Retirement System
Arizona
– -$2.83M -8,951 Closed
HWAM
162
Hennion & Walsh Asset Management
New Jersey
– -$2.77M -8,763 Closed
Stifel Financial
163
Stifel Financial
Missouri
– -$2.69M -8,507 Closed
SCS
164
Syquant Capital SAS
France
– -$2.57M -8,130 Closed
Principal Financial Group
165
Principal Financial Group
Iowa
– -$2.5M -7,910 Closed
GGHC
166
Gilder Gagnon Howe & Co
New York
– -$2.42M -7,657 Closed
EAM
167
EFG Asset Management
Oregon
– -$2.38M -7,514 Closed
Teacher Retirement System of Texas
168
Teacher Retirement System of Texas
Texas
– -$2.34M -7,402 Closed
MOACM
169
Mutual of America Capital Management
New York
– -$2.31M -7,311 Closed
Handelsbanken Fonder
170
Handelsbanken Fonder
Sweden
– -$2.22M -7,000 Closed
AB
171
Amalgamated Bank
New York
– -$2.21M -6,986 Closed
PA
172
Profund Advisors
Maryland
– -$2.18M -6,895 Closed
BCI
173
Brinker Capital Investments
Pennsylvania
– -$2.17M -6,848 Closed
OPS
174
Orion Portfolio Solutions
Nebraska
– -$2.17M -6,848 Closed
TAL
175
TIG Advisors LLC
New York
– -$2.07M -6,551 Closed
5 6
7
8 9

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.